Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

109 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Optimizing tacrolimus therapeutic drug monitoring in Tunisian kidney transplant recipients: exploring the variability in bioavailability and the correlation between pharmacokinetic parameters.
Aloui G, Charfi R, Daldoul M, Ben Hammamia S, Ben Sassi M, Zouari M, Eljeberi H, Daghfous R, Gaies E, Trabesli S. Aloui G, et al. Among authors: daghfous r. Drug Metab Pers Ther. 2024 Dec 16;39(4):215-220. doi: 10.1515/dmpt-2024-0043. eCollection 2024 Dec 1. Drug Metab Pers Ther. 2024. PMID: 39679494
Communicating for the Safe Use of Medicines: Progress and Directions for the 2020s Promoted by the Special Interest Group of the International Society of Pharmacovigilance.
Bahri P, Bowring G, Edwards BD, Anton C, Aronson JK, Caro-Rojas A, Hugman BPJ, Mol PG, Trifirò G, Ilic K, Daghfous R, Fermont I, Furlan G, Gaissmaier W, Geer MI, Hartigan-Go KY, Houÿez F, Neth H, Norgela G, Oppamayun Y, Raynor DKT, Bouhlel M, Santoro F, Sultana J. Bahri P, et al. Among authors: daghfous r. Drug Saf. 2023 Jun;46(6):517-532. doi: 10.1007/s40264-023-01285-5. Epub 2023 May 23. Drug Saf. 2023. PMID: 37219785 Free PMC article. Review. No abstract available.
Oxybutynin induced blindness in a child: Case report.
Daldoul M, Zaiem A, Mahjoubi YS, Charfi O, Lakhoua G, Kastalli S, Daghfous R, Aouinti I, El Aidli S. Daldoul M, et al. Among authors: daghfous r. Therapie. 2024 Nov 22:S0040-5957(24)00200-2. doi: 10.1016/j.therap.2024.11.003. Online ahead of print. Therapie. 2024. PMID: 39665910 No abstract available.
Factors influencing valproic acid trough levels in epileptic children.
Ferchichi K, Charfi R, Ben Hammamia S, Ben Sassi M, Gaies E, Daldoul M, Daghfous R, Trabelsi S. Ferchichi K, et al. Among authors: daghfous r. Tunis Med. 2024 Oct 5;102(10):690-695. doi: 10.62438/tunismed.v102i10.4881. Tunis Med. 2024. PMID: 39441169 Free PMC article. English.
Myocarditis following Coronavirus vaccination.
Ferchichi K, Aouinti I, Zaiem A, Lakhoua G, Kaabi W, Charfi O, Kastalli S, Daghfous R, Aidli SE. Ferchichi K, et al. Among authors: daghfous r. Clin Immunol Commun. 2022 Dec;2:162-164. doi: 10.1016/j.clicom.2022.11.001. Epub 2022 Nov 17. Clin Immunol Commun. 2022. PMID: 38013968 Free PMC article.
Cutaneous adverse effects of antiepileptic drugs.
Zgolli F, Aouinti I, Charfi O, Kaabi W, Hamza I, Daghfous R, Kastalli S, Lakhoua G, Aidli SE. Zgolli F, et al. Among authors: daghfous r. Therapie. 2024 Jul-Aug;79(4):453-459. doi: 10.1016/j.therap.2023.09.005. Epub 2023 Oct 4. Therapie. 2024. PMID: 37865562
Neurotoxicity following atezolizumab in a patient with tolerated rechallenge.
Salem Mahjoubi Y, Aouinti I, Charfi O, Zaiem A, Kaabi W, Lakhoua G, Daghfous R, El Aidli S. Salem Mahjoubi Y, et al. Among authors: daghfous r. Therapie. 2024 May-Jun;79(3):393-396. doi: 10.1016/j.therap.2023.03.007. Epub 2023 Mar 17. Therapie. 2024. PMID: 37730448 No abstract available.
109 results